Biologics

Histogenics Corporation to Present at Upcoming Investor Conferences
Biologics

Histogenics Corporation to Present at Upcoming Investor Conferences

WALTHAM, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, today announced that Company Management will be presenting at two upcoming healthcare investor conferences. Cowen and Company 37th Annual Health Care Conference – Boston, […]

Tissue Regenix Introduces Revolutionary dCELL® Platform Technology to the United States
Biologics Top Stories

Tissue Regenix Introduces Revolutionary dCELL® Platform Technology to the United States

February 23, 2017 09:03 AM Eastern Standard Time SAN ANTONIO–(BUSINESS WIRE)–Tissue Regenix, the U.K.-based leader in regenerative medicine, has established its decellularization (dCELL®) Technology in wound care in the United States with plans to expand into other medical sectors. The company has opened up new possibilities in regenerative medicine in […]

SANUWAVE Announces Hiring of Andre Mouton as VP of International Sales and Relations
Biologics

SANUWAVE Announces Hiring of Andre Mouton as VP of International Sales and Relations

SUWANEE, GA–(Marketwired – Feb 21, 2017) – SANUWAVE Health, Inc. ( OTCQB : SNWV ) is pleased to announce the hiring of André Mouton to head the Company’s international sales and relations. SANUWAVE began a process 18 months ago of re-igniting their international efforts. This meant re-designing distribution agreements, restructuring partner economics, […]

Asterias Biotherapeutics Extends the Expiration Date of Certain Warrants and Provides Update on Cash Position
Biologics

Asterias Biotherapeutics Extends the Expiration Date of Certain Warrants and Provides Update on Cash Position

FREMONT, Calif., Feb. 3, 2017 /PRNewswire/ — Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of regenerative medicine, today announced the company is extending the expiration date of certain warrants. The decision to extend the warrants takes into consideration Asterias’ recent announcement of positive interim efficacy results […]

Kuros closes acquisition of Xpand creating a leading commercial-stage orthobiologics company
Biologics

Kuros closes acquisition of Xpand creating a leading commercial-stage orthobiologics company

25 Jan 17 Kuros Biosciences (SIX:KURN) today announced the closing of the all-share strategic acquisition of Xpand Biotechnology B.V. of Bilthoven, the Netherlands. The takeover accelerates Kuros’ transition to commercial stage with two products expected to be ready for commercialization in the European Union this year, one of which may […]